Phosphorylcholine-targeting vaccination reduces experimental atherosclerosis progression by expanding the B1-like specific B cell pool

Saved in:
Bibliographic Details
Published inAtherosclerosis Vol. 331; p. e13
Main Authors Nicoletti, A., Even, G., Kozma, M. Ozsvar, Procopio, E., Gaston, A.-T., Binder, C.J., Caligiuri, G.
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.08.2021
Online AccessGet full text

Cover

More Information
ISSN:0021-9150
1879-1484
DOI:10.1016/j.atherosclerosis.2021.06.043